Calvin Sandra bought TVTX

November 4, 2025 · Form 4 insider transaction

Calvin Sandra bought 15,000 shares of Travere Therapeutics, Inc. at $27.50 per share, a transaction worth $412.5K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.